Literature DB >> 30552091

Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.

Chiara Autilio1,2, Jesús Pérez-Gil1,2.   

Abstract

Pulmonary surfactant (PS) is a lipid-protein complex essential to stabilise the delicate structure of mammalian alveoli along with successive compression-expansion respiratory cycles. To do so, surfactant reduces dramatically surface tension at the air-liquid interface, an activity that depends critically on a proper lipid composition and the presence of some specific surfactant proteins. Lack or dysfunction of this system is associated with severe respiratory pathologies, which are in some cases treated by supplementation with exogenous surfactant materials. The biophysical function and performance of PS, in health and disease, are directly influenced by its composition, structure and mechanical properties. This review summarises the main biophysics concepts behind the mechanisms that define surfactant function in a healthy lung and in pathological situations. It also revises some of the most useful biophysical techniques that provide information about surfactant-related processes. Finally, translational biophysics will be invoked to illustrate how biophysical studies may contribute to understand the role of surfactant in health and disease and to design better surfactant-based therapeutic approaches. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ARDS; air-liquid interface; breathing mechanics; lung surfactant; respiratory

Mesh:

Substances:

Year:  2018        PMID: 30552091     DOI: 10.1136/archdischild-2018-315413

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  25 in total

1.  Inflammation product effects on dilatational mechanics can trigger the Laplace instability and acute respiratory distress syndrome.

Authors:  Sourav Barman; Michael L Davidson; Lynn M Walker; Shelly L Anna; Joseph A Zasadzinski
Journal:  Soft Matter       Date:  2020-07-29       Impact factor: 3.679

2.  Genomic and epigenomic adaptation in SP-R210 (Myo18A) isoform-deficient macrophages.

Authors:  Eric Yau; Yan Chen; Chunhua Song; Jason Webb; Marykate Carillo; Yuka Imamura Kawasawa; Zhenyuan Tang; Yoshinori Takahashi; Todd M Umstead; Sinisa Dovat; Zissis C Chroneos
Journal:  Immunobiology       Date:  2021-10-25       Impact factor: 3.144

Review 3.  Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components.

Authors:  Dan Li; Xianzheng Wang; Yingzhao Liao; Shouchuan Wang; Jinjun Shan; Jianjian Ji
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

4.  Mechanobiology of Pulmonary Diseases: A Review of Engineering Tools to Understand Lung Mechanotransduction.

Authors:  Caymen Novak; Megan N Ballinger; Samir Ghadiali
Journal:  J Biomech Eng       Date:  2021-11-01       Impact factor: 2.097

5.  Carrier Solvents of Electronic Nicotine Delivery Systems Alter Pulmonary Surfactant.

Authors:  Nathalie Hayeck; Carl Zoghzoghi; Ebrahim Karam; Rola Salman; Nareg Karaoghlanian; Alan Shihadeh; Thomas Eissenberg; Salah Zein El Dine; Najat A Saliba
Journal:  Chem Res Toxicol       Date:  2021-05-04       Impact factor: 3.739

Review 6.  Alveolar lipids in pulmonary disease. A review.

Authors:  Christina W Agudelo; Ghassan Samaha; Itsaso Garcia-Arcos
Journal:  Lipids Health Dis       Date:  2020-06-03       Impact factor: 3.876

7.  All-Atom Molecular Dynamics Simulations of Dimeric Lung Surfactant Protein B in Lipid Multilayers.

Authors:  Nicholas A S Robichaud; Mohammad Hassan Khatami; Ivan Saika-Voivod; Valerie Booth
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 8.  Alveolar Dynamics and Beyond - The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis.

Authors:  Kirsten Sehlmeyer; Jannik Ruwisch; Nuria Roldan; Elena Lopez-Rodriguez
Journal:  Front Physiol       Date:  2020-05-05       Impact factor: 4.566

9.  Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations.

Authors:  Alberto Hidalgo; Cristina Garcia-Mouton; Chiara Autilio; Pablo Carravilla; Guillermo Orellana; Mohammad N Islam; Jahar Bhattacharya; Sunita Bhattacharya; Antonio Cruz; Jesús Pérez-Gil
Journal:  J Control Release       Date:  2020-11-24       Impact factor: 9.776

10.  Polyhydroxyalkanoate Nanoparticles for Pulmonary Drug Delivery: Interaction with Lung Surfactant.

Authors:  Olga Cañadas; Andrea García-García; M Auxiliadora Prieto; Jesús Pérez-Gil
Journal:  Nanomaterials (Basel)       Date:  2021-06-03       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.